Medical Information
United States

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

THROMBIN-JMI®Warnings and Precautions (thrombin, topical, bovine origin)


Warning: Severe Bleeding and Thrombosis Complications

5.1 Hypersensitivity Reactions

Allergic reactions, including anaphylactic/anaphylactoid reactions, have been reported following administration of THROMBIN-JMI.
Institute intensive supportive measures and treat individual symptoms. Secure the airway and establish adequate respiratory exchange.

5.2 Thrombosis

THROMBIN-JMI causes thrombosis if it enters the circulatory system. Apply topically. DO NOT INJECT.

5.3 Immunogenicity

Inhibitory antibodies may develop in patients and interfere with hemostasis. Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event